AMPH icon

Amphastar Pharmaceuticals
AMPH

Overview Fund Activity

114 hedge funds and large institutions have $307M invested in Amphastar Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 38 reducing their positions, and 15 closing their positions.

Holders
114
Holders Change
-2
Holders Change %
-1.72%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
40
Reduced
38
Closed
15
Calls
–
Puts
$154K
Net Calls
-$154K
Net Calls Change
-$198K

Top Buyers

1
BlackRock
1
BlackRock
New York
$87.3M
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$19.5M
3
CAM
3
Cortina Asset Management
Wisconsin
$5.99M
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$27M
5
Goldman Sachs
5
Goldman Sachs
New York
$4.06M

Top Sellers

1
Invesco
1
Invesco
Georgia
$4.71M
2
MWNA
2
Marshall Wace North America
New York
$0
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$302K
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
Fisher Asset Management
5
Fisher Asset Management
Washington
$1.99M
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
126
Prelude Capital Management
New York
– – -1,750 Closed
PFBT
127
Parkside Financial Bank & Trust
Missouri
$0 29 -29 -50%
VCM
128
Versant Capital Management
Arizona
$0 15 – –
CG
129
Cutler Group
California
– – – –
WAM
130
Wealthspire Advisors (Maryland)
Maryland
$0 6 – –
2 3 4 5
6